Patent · US Active

Aminoquinoline derivatives and their use as adenosine A3 ligands

US8071601B2 · kind B2 · utility

0Cited by
1References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 18, 2011
Grant dateDec 6, 2011
Priority date—
Expiry dateJan 18, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D491/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to an adenosine A3 receptor ligand of the general formula (I).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.